Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Gain Therapeutics (NASDAQ:GANX) through any online brokerage.
Other companies in Gain Therapeutics’s space includes: Molecular Partners AG (NASDAQ:MOLN), Kalaris Therapeutics Inc (NASDAQ:KLRS), Burning Rock Biotech Ltd (NASDAQ:BNR), Inovio Pharmaceuticals Inc (NASDAQ:INO) and Elicio Therapeutics Inc (NASDAQ:ELTX).
Gain Therapeutics has a consensus price target of $8.00.
The stock price for Gain Therapeutics (NASDAQ: GANX) is $3.8946 last updated December 16, 2025 at 7:59 PM EST.
There are no upcoming dividends for Gain Therapeutics.
Gain Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Gain Therapeutics.
Gain Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.